RBC Adjusts Price Target on Regeneron Pharmaceuticals to $1,059 From $1,184, Maintains Outperform Rating

MT NewswiresJan 22 21:23 · Ratings

Morgan Stanley Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Cuts Target Price to $1,185

Futu NewsJan 21 21:31 · Ratings

Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): 'This Company Has Never Lost Its Ability To Develop New Medicines'

Yahoo FinanceJan 19 19:17

$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

BenzingaJan 16 23:30

Express News | Regeneron Pharmaceuticals Inc : UBS Cuts to Neutral From Buy

BreakingsJan 16 19:41

UBS Downgrades Regeneron Pharmaceuticals(REGN.US) to Hold Rating, Cuts Target Price to $738

Futu NewsJan 16 18:33 · Ratings